ATE331037T1 - Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff - Google Patents

Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff

Info

Publication number
ATE331037T1
ATE331037T1 AT96912605T AT96912605T ATE331037T1 AT E331037 T1 ATE331037 T1 AT E331037T1 AT 96912605 T AT96912605 T AT 96912605T AT 96912605 T AT96912605 T AT 96912605T AT E331037 T1 ATE331037 T1 AT E331037T1
Authority
AT
Austria
Prior art keywords
nucleic acid
frpb
acid molecule
isolated
corresponding vaccine
Prior art date
Application number
AT96912605T
Other languages
English (en)
Inventor
P Fredrick Sparling
Margaret Beucher
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Application granted granted Critical
Publication of ATE331037T1 publication Critical patent/ATE331037T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96912605T 1995-04-07 1996-04-08 Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff ATE331037T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41896495A 1995-04-07 1995-04-07

Publications (1)

Publication Number Publication Date
ATE331037T1 true ATE331037T1 (de) 2006-07-15

Family

ID=23660253

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96912605T ATE331037T1 (de) 1995-04-07 1996-04-08 Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff

Country Status (8)

Country Link
US (3) US6265567B1 (de)
EP (1) EP0830456B1 (de)
JP (1) JP3797490B2 (de)
AT (1) ATE331037T1 (de)
AU (1) AU5537096A (de)
CA (1) CA2217522C (de)
DE (1) DE69636285D1 (de)
WO (1) WO1996031618A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule
RU2347813C2 (ru) * 1997-11-06 2009-02-27 Чирон С.П.А. Антигены нейссерий
EP1029052B1 (de) * 1997-11-06 2010-08-04 Novartis Vaccines and Diagnostics S.r.l. Neisseriale antigene
US6914131B1 (en) 1998-10-09 2005-07-05 Chiron S.R.L. Neisserial antigens
GB9808866D0 (en) * 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
AU3968599A (en) * 1998-04-29 1999-11-16 American Cyanamid Company Vaccines containing recombinant pilin against Neisseria Gonorrhoeae or Neisseria Meningitidis
CN100379757C (zh) * 1998-05-01 2008-04-09 希龙公司 脑膜炎奈瑟球菌抗原和组合物
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
US6692752B1 (en) 1999-09-08 2004-02-17 Smithkline Beecham Biologicals S.A. Methods of treating human females susceptible to HSV infection
EP1144643A1 (de) 1999-01-15 2001-10-17 SMITHKLINE BEECHAM BIOLOGICALS s.a. Neisseria meningitidis antigen
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
PT2275551E (pt) * 1999-10-29 2015-06-29 Novartis Vaccines & Diagnostic Péptidos antigénicos de neisseria
ES2281409T3 (es) 2000-02-28 2007-10-01 Novartis Vaccines And Diagnostics S.R.L. Expresion heterologa de proteinas de neisseria.
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
GB0220199D0 (en) * 2002-08-30 2002-10-09 Univ Utrecht Mutant protein and refolding method
DE20321889U1 (de) 2002-08-02 2012-03-12 Glaxosmithkline Biologicals S.A. Impfstoffzusammensetzung
DK1556477T3 (en) 2002-11-01 2017-10-23 Glaxosmithkline Biologicals Sa Process for drying
GB2414667A (en) * 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
EP2032161B1 (de) 2006-06-12 2012-07-11 GlaxoSmithKline Biologicals S.A. L3v los impfstoffe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule

Also Published As

Publication number Publication date
CA2217522C (en) 2011-09-20
EP0830456A1 (de) 1998-03-25
US6265567B1 (en) 2001-07-24
US20030096368A1 (en) 2003-05-22
US20050271681A1 (en) 2005-12-08
DE69636285D1 (de) 2006-08-03
WO1996031618A1 (en) 1996-10-10
EP0830456B1 (de) 2006-06-21
EP0830456A4 (de) 2001-03-14
AU5537096A (en) 1996-10-23
JP3797490B2 (ja) 2006-07-19
CA2217522A1 (en) 1996-10-10
JPH11503322A (ja) 1999-03-26

Similar Documents

Publication Publication Date Title
DE69636285D1 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
DK0758248T3 (da) Formuleringer til faktor IX
DE69729786D1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
DE69620877D1 (de) Arzneimittelformulierungen für il-12
ATE196913T1 (de) Neuartige peptidderivate
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
DK1200418T3 (da) Nematodicide trifluorbutener
NO983999L (no) Peptidimmunogener for vaksinasjon mot og behandling av allergi
TR200101867T2 (tr) CCR5 modülatörleri olarak piperidinler
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
CY1106366T1 (el) Ενωση λακταμης για την αναστολη της απελευθερωσης ή της συνθεσης βητα-αμυλοειδους πεπτιδιου
TR200806259T2 (tr) Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
NO990405L (no) Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE210988T1 (de) Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen
DK0705100T3 (da) Terapeutiske substituerede guanidiner
PT789590E (pt) Imunopotenciacao induzida por quitosano
CY1105235T1 (el) Συνθεσεις λασοφοξιφενης
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
ATE201693T1 (de) Hämoregulierende peptide
AU5163598A (en) Novel hepatitis b inhibitors
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
DE69619123D1 (de) Hämoregulatorische verbindungen
DK0579765T3 (da) Fremgangsmåde og præparat til behandling af herpes-relaterede sygdomme

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties